Showing 1,868 news articles about Access to healthcare

Filters Content type: Editors' picks Topic: Access to healthcare

News and information about universal access to health care; the impact of restrictive policies and financial challenges on access to treatment; drug stock-outs; and scaling up services.

Access to healthcare

South African report spotlights ‘system-wide slide’ in basics for health facility standards after Pepfar cuts

Editor's pick
Daily Maverick
23 October 2025
Injectable & long-acting PrEP

South African firms lose out on lenacapavir production

Editor's pick
Juta MedicalBrief
23 October 2025
Pharmaceutical industry

HIV Preventive Treatment Could Be Sold for One Thousandth of Current List Price

Editor's pick
Infectious Disease Society of America
21 October 2025
Health services & systems

HIV Providers: Shortages and Uneven Distribution Across the US

Editor's pick
Contagion Live
21 October 2025
PrEP policies & guidelines

Joint Statement: Activists Demand $40-a-Year Generic Price for Breakthrough HIV Prevention Drug Be Made Available to All Low- and Middle Income Countries

Editor's pick
Treatment Action Group
25 September 2025
PrEP policies & guidelines

Two drugmakers will sell the 6-monthly anti-HIV jab for the price of the daily HIV prevention pill

Editor's pick
Bhekisisa
24 September 2025
Injectable & long-acting PrEP

Support for Indian Manufacturers to Produce Cheap Generics of HIV ‘Miracle’ Drug, Lenacapavir

Editor's pick
Health Policy Watch
24 September 2025
Access to healthcare

Love, drugs and condoms: Couples with different HIV status in Kenya face a new reality

Editor's pick
NPR
11 September 2025
PrEP policies & guidelines

U.S. will fulfill Biden-era pledge to provide lenacapavir PrEP to millions

Editor's pick
Science
8 September 2025
Injectable & long-acting PrEP

Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries

Editor's pick
Gilead Sciences press release
5 September 2025
Access to healthcare

PrEP Insurance Denials Occur Frequently in U.S., Nationwide Survey Reveals

Editor's pick
TheBodyPro
4 September 2025
Access to healthcare

Malawi set to run out of TB drugs in a month after US, UK and others cut aid

Editor's pick
The Guardian
28 August 2025
Access to healthcare

Botswana declares national public health emergency as clinics run out of medicine

Editor's pick
BBC News
26 August 2025
Access to healthcare

South Africa's most vulnerable struggle to find HIV medication after US aid cuts

Editor's pick
ABC News
25 August 2025
Finance & funding

Keeping HIV Treatment Costs Down: What Can the U.S. Learn From the Netherlands?

Editor's pick
TheBodyPro
25 August 2025
Government, leadership & policy

Zimbabwe: HIV Funding Cuts Undermine Years of Progress

Editor's pick
MSF
25 August 2025
PrEP policies & guidelines

For now, CVS declines to cover Gilead's long-acting HIV PrEP treatment Yeztugo

Editor's pick
FiercePharma
25 August 2025
Government, leadership & policy

A proposed California bill aims to protect coverage for HIV prevention despite federal threats

Editor's pick
Los Angeles Times
9 August 2025
PrEP policies & guidelines

Gilead’s Regulatory Delays Block Access to Lenacapavir for PrEP

Editor's pick
Health GAP (Global Access Project)
4 August 2025
Access to healthcare

US: The Coming HIV Care Crisis

Editor's pick
HIV-HCV Co-Infection Watch
16 July 2025
Injectable & long-acting PrEP

New Analysis Exposes Path to Affordable Lenacapavir for HIV Prevention

Editor's pick
ITPC Global
16 July 2025
Access to healthcare

Dutch survey finds informal use of doxyPEP is rising

Editor's pick
CIDRAP
10 July 2025
Injectable & long-acting PrEP

Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries

Editor's pick
Global Fund News Releases
10 July 2025
Injectable & long-acting PrEP

Gilead to provide HIV prevention drug to 2 million people in lower-income countries at cost

Editor's pick
STAT (requires free registration)
10 July 2025